Fever in the neutropenic patient following myelosuppressive chemothera
py is a medical emergency. Appropriate antimicrobial therapy can drama
tically reduce infection-related morbidity and mortality. This article
reviews the rationale and methodology of treatment as well as its app
licability to other neutropenic states. The utility of adjunct therapy
with granulocyte- stimulating compounds is also discussed.